|
1
|
Gong S, Wang H, Zhang H, Liu W, Zhang X
and Zhao C: Real-world data on the dose-related effect of arsenic
trioxide in the relapse of acute promyelocytic leukemia. Mol Clin
Oncol. 213(91)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sanz MA, Fenaux P, Tallman MS, Estey EH,
Löwenberg B, Naoe T, Lengfelder E, Döhner H, Burnett AK, Chen SJ,
et al: Management of acute promyelocytic leukemia: Updated
recommendations from an expert panel of the European LeukemiaNet.
Blood. 133:1630–1643. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Santolaria A, Perales A, Montesinos P and
Sanz MA: A cute promyelocytic leukemia during pregnancy: A
systematic review of the literature. Cancers (Basel).
12(968)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Saleh AJ, Alhejazi A, Ahmed SO, Al Mohareb
F, AlSharif F, AlZahrani H, Mohamed SY, Rasheed W, AlDawsari G,
Ibrahim K, et al: Leukemia during pregnancy: Long term follow up of
32 cases from a single institution. Hematol Oncol Stem Cell Ther.
7:63–68. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Jain N, Hubbard J, Vega F, Vidal G,
Garcia-Manero G and Borthakur G: Spontaneous remission of acute
myeloid leukemia: Report of three cases and review of the
literature. Clin Leuk. 2:64–67. 2008.
|
|
6
|
Pentheroudakis G, Orecchia R, Hoekstra HJ
and Pavlidis N: ESMO Guidelines Working Group. Cancer, fertility
and pregnancy: ESMO clinical practice guidelines for diagnosis,
treatment and follow-up. Ann Oncol. 21 (Suppl 5):v266–v273.
2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chelghoum Y, Vey N, Raffoux E, Huguet F,
Pigneux A, Witz B, Pautas C, de Botton S, Guyotat D, Lioure B, et
al: Acute leukemia during pregnancy: A report on 37 patients and a
review of the literature. Cancer. 104:110–117. 2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rizack T, Mega A, Legare R and Castillo J:
Management of hematological malignancies during pregnancy. Am J
Hematol. 84:830–841. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Azim HA, Pavlidis N and Peccatori FA:
Treatment of the pregnant mother with cancer: A systematic review
on the use of cytotoxic, endocrine, targeted agents and
immunotherapy during pregnancy. Part II: Hematological tumors.
Cancer Treat Rev. 36:110–121. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fenaux P, Chevret S, Guerci A, Fegueux N,
Dombret H, Thomas X, Sanz M, Link H, Maloisel F, Gardin C, et al:
Long-term followup confirms the benefit of all-trans retinoic acid in
acute promyelocytic leukemia. European APL group. Leukemia.
14:1371–1377. 2000.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Valappil S, Kurkar M and Howell R: Outcome
of pregnancy in women treated with all-trans retinoic acid: A case
report and review of literature. Hematology. 12:415–418.
2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Giagounidis AA, Beckmann MW, Giagounidis
AS, Aivado M, Emde T, Germing U, Riehs T, Heyll A and Aul C: Acute
promyelocytic leukemia and pregnancy. Eur J Haematol. 64:267–271.
2002.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hoonjan M, Jadhav V and Bhatt P: Arsenic
trioxide: Insights into its evolution to an anticancer agent. J
Biol Inorg Chem. 23:313–329. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pagnano KB, Rego EM, Rohr S, Chauffaille
Mde L, Jacomo RH, Bittencourt R, Firmato AB, Fagundes EM, Melo RA
and Bernardo W: Guidelines on the diagnosis and treatment for acute
promyelocytic leukemia: Associação Brasileira de Hematologia,
Hemoterapia e Terapia Celular guidelines project: Associação Médica
Brasileira-2013. Rev Bras Hematol Hemoter. 36:71–92.
2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Caldwell KE, Labrecque MT, Solomon BR, Ali
A and Allan AM: Prenatal arsenic exposure alters the programming of
the glucocorticoid signaling system during embryonic development.
Neurotoxicol Teratol. 47:66–79. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Samanta G, Das D, Mandal BK, Chowdhury TR,
Chakraborti D, Pal A and Ahamed S: Arsenic in the breast milk of
lactating women in arsenic-affected areas of West Bengal, India and
its effect on infants. J Environ Sci Health A Tox Hazard Subst
Environ Eng. 42:1815–1825. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nyanza EC, Dewey D, Manyama M, Martin JW,
Hatfield J and Bernier FP: Maternal exposure to arsenic and mercury
and associated risk of adverse birth outcomes in small-scale gold
mining communities in northern Tanzania. Environ Int.
137(105450)2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Vahter M, Skröder H, Rahman SM, Levi M,
Derakhshani Hamadani J and Kippler M: Prenatal and childhood
arsenic exposure through drinking water and food and cognitive
abilities at 10 years of age: A prospective cohort study. Environ
Int. 139(105723)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Naithani R, Dayal N, Chopra A and Sundar
J: Fetal outcome in pregnancy with acute promyelocytic leukemia.
Indian J Paediatr. 83:752–753. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Fei F, Faye-Petersen OM, Vachhani P, Jamy
O and Reddy VV: Acute promyelocytic leukemia during pregnancy: A
case report and 10-year institutional review of hematologic
malignancies during pregnancy. Pathol Res Pract.
215(152672)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cochet C, Simonet M, Cattin J, Metz JP,
Berceanu A, Deconinck E, Daguindau E, Schillinger F, Fenaux P,
Mottet N and Desbrosses Y: Arsenic trioxide treatment during
pregnancy for acute promyelocytic leukemia in a 22-year-old woman.
Case Rep Hematol. 2020(3686584)2020.PubMed/NCBI View Article : Google Scholar
|
